In hepatocellular carcinoma, Wang et al found c-Myc collaborates with EZH2-containing PRC2 complex in silencing miRNA-101 during hepatocarcinogenesis and lower expression of miR-101 is positively correlated with poorer prognosis [38]. The gene discussed is MYC; the disease is hepatocellular carcinoma.